Michael Y Bonner

Michael Y Bonner

UNVERIFIED PROFILE

Are you Michael Y Bonner?   Register this Author

Register author
Michael Y Bonner

Michael Y Bonner

Publications by authors named "Michael Y Bonner"

Are you Michael Y Bonner?   Register this Author

33Publications

1040Reads

23Profile Views

Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer.

Biochim Biophys Acta Gen Subj 2018 May 28. Epub 2018 May 28.

Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2018.05.018DOI Listing
May 2018

Activation of Protein Kinase C ε in Merkel Cell Polyomavirus-Induced Merkel Cell Carcinoma.

JAMA Dermatol 2017 09;153(9):931-932

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2017.1296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817431PMC
September 2017

Targeting the duality of cancer.

NPJ Precis Oncol 2017 22;1. Epub 2017 Jun 22.

Department of Dermatology, Emory University School of Medicine, Atlanta Veterans Administration Medical Center, Winship Cancer Institute, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41698-017-0026-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559615PMC
June 2017

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis.

Breast Cancer Res 2017 03 28;19(1):39. Epub 2017 Mar 28.

Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0829-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368940PMC
March 2017

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies.

Molecules 2016 Jul 30;21(8). Epub 2016 Jul 30.

Department of Experimental Hematology of Medical University of Lodz, Ciołkowskiego 2 Street, Lodz 93-510, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules21080995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274336PMC
July 2016

Tuberculosis verrucosa cutis lesions exhibit a greater microvessel count than lupus vulgaris lesions.

Exp Dermatol 2016 06 12;25(6):479-80. Epub 2016 May 12.

Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.12980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880505PMC
June 2016

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.

Oncotarget 2016 Mar;7(11):12857-68

Department of Dermatology, Emory School of Medicine, and Winship Cancer Institute, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914326PMC
March 2016

Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our Respect.

J Invest Dermatol 2016 Mar;136(3):564-566

Department of Dermatology, Emory School of Medicine, and Winship Cancer Institute, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2015.12.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925755PMC
March 2016

Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.

Oncotarget 2015 Oct;6(30):29947-62

Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745774PMC
October 2015

The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

Future Med Chem 2014 ;6(12):1413-22

Department of Dermatology, Winship Cancer Institute, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc.14.86DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412352PMC
August 2015

Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.

Oncotarget 2015 Jun;6(18):16396-410

Department of Oncology, Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599277PMC
http://dx.doi.org/10.18632/oncotarget.3844DOI Listing
June 2015

Solenopsin A and analogs exhibit ceramide-like biological activity.

Vasc Cell 2015 8;7. Epub 2015 May 8.

Department of Dermatology, Emory University School of Medicine, Atlanta, GA USA ; Atlanta Veterans Administration Hospital, and Winship Cancer Institute, Emory University, Atlanta, GA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13221-015-0030-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443652PMC
May 2015

Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage.

Radiat Res 2015 Mar 23;183(3):262-70. Epub 2015 Feb 23.

a Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1667/RR13799.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423734PMC
March 2015

NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease.

Proc Natl Acad Sci U S A 2015 Feb 2;112(7):2121-6. Epub 2015 Feb 2.

Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1418139112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343117PMC
February 2015

Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.

Mol Oncol 2014 May 15;8(3):565-80. Epub 2014 Jan 15.

Department of Oncology, Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009450PMC
May 2014

Honokiol inhibits androgen receptor activity in prostate cancer cells.

Prostate 2014 Apr 11;74(4):408-20. Epub 2013 Dec 11.

Department of Pharmacology & Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946953PMC
April 2014

In vivo Gram staining of tinea versicolor.

JAMA Dermatol 2013 Aug;149(8):991-2

Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia2Atlanta Veterans Administration Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2013.2699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925416PMC
August 2013

Targeting NADPH oxidases for the treatment of cancer and inflammation.

Cell Mol Life Sci 2012 Jul 13;69(14):2435-42. Epub 2012 May 13.

Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-012-1017-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405775PMC
July 2012

Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia.

Vasc Cell 2012 Jul 5;4(1):11. Epub 2012 Jul 5.

Department of Dermatology, Emory University School of Medicine; Winship Cancer Institute and Atlanta Veterans Administration Hospital, WMB 5309, 1639 Pierce Drive, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://vascularcell.com/index.php/vc/article/view/10.1186-20
Publisher Site
http://dx.doi.org/10.1186/2045-824X-4-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464934PMC
July 2012

Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.

Sci Transl Med 2012 Mar;4(127):127ra36

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003016DOI Listing
March 2012

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.

Breast Cancer Res 2012 Feb 21;14(1):R35. Epub 2012 Feb 21.

Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496153PMC
February 2012